{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:07:06Z","timestamp":1775070426211,"version":"3.50.1"},"reference-count":11,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,10,1]]},"DOI":"10.1200\/jco.2008.16.1398","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T00:33:51Z","timestamp":1217291631000},"page":"4537-4538","source":"Crossref","is-referenced-by-count":21,"title":["Follicular Lymphoma, Survival, and Rituximab: Is It Time to Declare Victory?"],"prefix":"10.1200","volume":"26","author":[{"given":"Sandra J.","family":"Horning","sequence":"first","affiliation":[{"name":"Stanford University Medical Center, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1","unstructured":"Horning SJ: Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 20:75,1993-88,"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.503"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1674"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3696"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V110.11.3428.3428"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5376"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0016"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116749"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-089110"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Hochster HS, Weller E, Gascoyne RD, et al: Maintenance rituximab after CVP Results in superior clinical outcome in advanced follicular lymphoma (FL): Results of the E1496 phase III trial. Blood 106:349A,2005,","DOI":"10.1182\/blood.V106.11.349.349"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2008.16.1398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:20:42Z","timestamp":1653510042000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.16.1398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":11,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2008,10,1]]}},"alternative-id":["10.1200\/JCO.2008.16.1398"],"URL":"https:\/\/doi.org\/10.1200\/jco.2008.16.1398","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}